Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
A certain exchange and Glassnode report: Bitcoin is undervalued and market sentiment remains cautious

A certain exchange and Glassnode report: Bitcoin is undervalued and market sentiment remains cautious

AIcoinAIcoin2026/04/22 23:29
Show original
According to the "Q1 2026 Crypto Market Chart Analysis Report" released by a certain exchange Institutional and glassnode, 75% of institutional investors and 61% of non-institutional investors believe Bitcoin is undervalued. 82% of institutional investors and 70% of non-institutional investors think the market is in a bear market or late-bear phase, up from 31% and 36% in December. The supply of BTC moved within the past three months has dropped by 37%, while the supply unmoved for a year has risen by 1%. Bitcoin ETF cumulative capital inflows are approaching historical highs. The report points out that market sentiment is trending cautious, but fundamentals continue to improve.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.

The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.

智通财经2026/09/21 07:31

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11